For this reason, tumor with high levels of p16ink4a, like human papilloma virus-positive cancers (e.g., cervical cancer and squamous cell cancer of the head and neck district), would be resistant to CDK4/6 inhibitors [58]. The gene discussed is CDK4; the disease is cancer.